Suchergebnisse - "Vasudevan, Abhinav"

PubPharm (7)

1

Biomarker dynamics during infliximab salvage for acute severe ulcerative colitis : C-reactive protein (CRP)-lymphocyte ratio and CRP-albumin ratio are useful in predicting colectomy

enthalten in: Intestinal research | 2022

von Con, D. | Andrew, B. | Nicolaides, S. | +2

2

Assessing adherence to infusion-based biologic therapies in patients with inflammatory bowel disease

enthalten in: Research in social & administrative pharmacy : RSAP | 2021

von Haar, G. | Vasudevan, A. | Curtain, C. | +1

3

Approach to medical therapy in perianal Crohn's disease

enthalten in: World journal of gastroenterology | 2021

von Vasudevan, A. | Bruining, D. | Loftus, E. | +3

4

The impact of tobacco smoking on treatment choice and efficacy in inflammatory bowel disease

enthalten in: Intestinal research | 2021

von Nicolaides, S. | Vasudevan, A. | Long, T. | +1

5

Transitioning patients with inflammatory bowel disease from hospital-based to rapid home-based infliximab : A stepwise, safety and patient-orientated process towards sustainability

enthalten in: World journal of gastroenterology | 2020

von Bohra, A. | Rizvi, Q. | Keung, C. | +2

6

Inflammatory bowel disease and superior mesenteric artery thromboembolism

enthalten in: Intestinal research | 2020

von Nicolaides, S. | Vasudevan, A. | Langenberg, D.

7

Time to clinical response and remission for therapeutics in inflammatory bowel diseases : What should the clinician expect, what should patients be told?

enthalten in: World journal of gastroenterology | 2017

von Vasudevan, A. | Gibson, P. | van Langenberg, D.

1
[1]